Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIB Skin Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05234437
What this trial is testing

A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma

Who this might be right for
Melanoma
QBiotics Group Limited 1
Large-scale testing (Phase 3)Study completedNCT02714218
What this trial is testing

Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 387
Large-scale testing (Phase 3)Ended earlyNCT02288897
What this trial is testing

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma
Provectus Biopharmaceuticals, Inc. 20
Early research (Phase 1)Study completedNCT01496807
What this trial is testing

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT02858921
What this trial is testing

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 60
Not applicableLooking for participantsNCT06754904
What this trial is testing

Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node

Who this might be right for
Melanoma, Skin
D.J. (Dirk) Grünhagen 213
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02231775
What this trial is testing

Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation

Who this might be right for
Stage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7
M.D. Anderson Cancer Center 58
Not applicableStudy completedNCT02857374
What this trial is testing

Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy

Who this might be right for
Stage IB Skin MelanomaStage IIA Skin MelanomaStage IIB Skin Melanoma+4 more
Roswell Park Cancer Institute 20
Not applicableWithdrawnNCT02507076
What this trial is testing

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Who this might be right for
Basal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinRecurrent Adult Soft Tissue Sarcoma+8 more
Albert Einstein College of Medicine
Testing effectiveness (Phase 2)Study completedNCT04330430
What this trial is testing

Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Melanoma with Injectable Disease

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
The Netherlands Cancer Institute 24
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Ended earlyNCT02587650
What this trial is testing

Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma

Who this might be right for
ALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more
University of California, San Francisco 1
Testing effectiveness (Phase 2)Study completedNCT02970981
What this trial is testing

Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma

Who this might be right for
Melanoma
NYU Langone Health 18
Large-scale testing (Phase 3)Study completedNCT00769704
What this trial is testing

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Who this might be right for
Melanoma
BioVex Limited 437
Testing effectiveness (Phase 2)Study completedNCT01972347
What this trial is testing

Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 35
Testing effectiveness (Phase 2)Study completedNCT02014441
What this trial is testing

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

Who this might be right for
Melanoma
Amgen 61
Testing effectiveness (Phase 2)WithdrawnNCT02812693
What this trial is testing

Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification

Who this might be right for
Stage IIIA Skin MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more
Joanne Jeter
Large-scale testing (Phase 3)Active Not RecruitingNCT02938299
What this trial is testing

Neoadjuvant L19IL2/L19TNF- Pivotal Study

Who this might be right for
Malignant Melanoma
Philogen S.p.A. 214
Testing effectiveness (Phase 2)Study completedNCT00003895
What this trial is testing

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

Who this might be right for
Recurrent MelanomaStage IA MelanomaStage IB Melanoma+6 more
National Cancer Institute (NCI) 36
Next Page